Published in Cancer on February 01, 1971
Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin Exp Immunol (1979) 1.50
The Epstein-Barr virus and its association with human cancers. Mol Pathol (1999) 1.26
Hodgkin's disease and the Epstein-Barr virus. Mol Pathol (2000) 1.15
Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol (1992) 1.11
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol (2007) 1.05
EBV-associated lymphomas in adults. Best Pract Res Clin Haematol (2012) 0.95
Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol (1991) 0.95
Epstein-Barr virus-induced epigenetic alterations following transient infection. Int J Cancer (2012) 0.92
Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. Yale J Biol Med (1987) 0.91
Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer (2001) 0.85
The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens (2016) 0.83
Epstein-Barr virus and the origin of Hodgkin lymphoma. Chin J Cancer (2014) 0.82
Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. Am J Pathol (1993) 0.80
Antibodies to Epstein-Barr virus in patients with cryptococcosis. J Clin Microbiol (1975) 0.76
In vitro susceptibilities of normal human skin fibroblasts to oncoviruses, and the decreased susceptibility to HSV of fibroblasts from untreated Hodgkin's patients. Br J Cancer (1981) 0.75
Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web. Yale J Biol Med (1974) 0.75
Thymus transplantation. Reconstitution of cellular immunity in a four-year-old patient with T-cell deficiency. Clin Exp Immunol (1975) 0.75
Role of immunologic disturbance in human oncogenesis: some facts and fancies. Br J Cancer (1971) 0.75
Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis. Can Med Assoc J (1973) 0.75
Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis. Open Virol J (2015) 0.75
Antinuclear antibodies and elevated anti-Epstein-Barr virus titers in cancer patients. Infect Immun (1976) 0.75
Immunological aspects of Hodgkin's disease. Proc R Soc Med (1972) 0.75
Antibody responses to herpesviruses (EBV, HSV and CMV) in cancer patients given cultured lymphoblastoid cells. Clin Exp Immunol (1972) 0.75
Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis (2017) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst (1985) 2.95
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol (2010) 2.94
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med (1988) 2.81
HBLV (or HHV-6) in human cell lines. Nature (1987) 2.53
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology (1978) 2.41
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood (1989) 2.37
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med (1974) 2.26
Genomic analysis of the human B-lymphotropic virus (HBLV). Science (1986) 2.23
Factor concentrates for treatment of hemophilia: which one to choose? Blood (1989) 2.16
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol (1989) 1.99
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (1989) 1.96
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88
Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virol (1989) 1.87
Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A (1992) 1.85
An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation (1973) 1.84
Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79
Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med (1997) 1.70
Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer (1999) 1.68
Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev (1993) 1.66
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood (1990) 1.64
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature (1984) 1.63
Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62
Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. J Hum Hypertens (2006) 1.62
Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology (1985) 1.60
Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer (1972) 1.55
Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med (1988) 1.51
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B. Ann Intern Med (1973) 1.46
Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med (1992) 1.46
The association between anthropometric parameters, the metabolic syndrome and microalbuminuria in black Africans: the SABPA study. Cardiovasc J Afr (2010) 1.45
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med (1972) 1.44
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Transfusion transmission of human T-lymphotropic virus types I and II: lessons to be learned from look-back investigations and implications for patient counseling. Transfusion (1993) 1.42
n-3 fatty acids and cellular aspects of atherosclerosis. Arch Intern Med (1989) 1.39
Acute intermittent porphyria. New morphologic and biochemical findings. Am J Med (1966) 1.38
Malignant lymphomas: current classification and new observations. Pathol Annu (1975) 1.38
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B. N Engl J Med (1974) 1.36
Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J Natl Cancer Inst (1974) 1.36
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A (1990) 1.36
Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science (1984) 1.35
Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients. Int J Cancer (1975) 1.35
Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.34
Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. Int J Cancer (1973) 1.34
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34
Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control (1999) 1.32
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer (1982) 1.32
Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32
Molecular studies of HHV-6. J Virol Methods (1988) 1.32
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Diverse tropism of HBLV (human herpesvirus 6) Lancet (1987) 1.29
Functional markers: a new perspective on malignant lymphomas. Cancer Treat Rep (1977) 1.29
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27
Intramolecular recombination as a source of mitochondrial chromosome heteromorphism in Neurospora. Cell (1984) 1.26
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol (1986) 1.26
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med (1967) 1.25
The American Burkitt's Lymphoma Registry: eight years' experience. Cancer (1982) 1.24
Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer (1980) 1.24
The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol (1990) 1.23
Health of the intensively treated hemophiliac, with special reference to abnormal liver chemistries and splenomegaly. Blood (1977) 1.23
Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol (1983) 1.23
Preparation of suspensions of small bowel mucosal epithelial cells. J Lab Clin Med (1970) 1.23
Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7. J Infect Dis (1992) 1.22
Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med (1976) 1.21
Evidence for exposure to HTLV-III in Uganda before 1973. Science (1985) 1.18
Antigenic relationships among human herpesvirus-6 isolates. J Med Virol (1992) 1.18
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes. J Virol (1991) 1.17
Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. Leukemia (1988) 1.17
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med (1980) 1.16
Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16